drugset / Trial / NCT07446400
A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together
Non-randomizedParallel-groupOpen-labelOther
Summary
The purpose of this study is to assess the drug-drug interaction (DDI) of repinatrabit with ethinyl estradiol/norethindrone or norethisterone (EE/NE), metformin, rosuvastatin, carbamazepine, and methotrexate in healthy participants.
Timeline
- Start
- 2026-03-31
- Primary completion
- 2026-06-09
- Completion
- 2026-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbamazepine | Small molecule | — | Oral |
| Subject | EE/NE | Unknown | — | Oral |
| Subject | JNT-517 | Unknown | — | Oral |
| Subject | Metformin | Small molecule | — | Oral |
| Subject | Methotrexate | Small molecule | — | Oral |
| Subject | Rosuvastatin | Small molecule | — | Oral |
Indications
No indication recorded.